Novavax, Inc.

NASDAQ:NVAX   3:59:57 PM EDT
53.83
+2.16 (+4.18%)
4:00:25 PM EDT: $53.87 +0.04 (+0.07%)
Business Deals

Mabion Signs Extension To The Scope Of Services Under Deal With Novavax

Published: 05/30/2022 05:45 GMT
Novavax, Inc. (NVAX) - Said on Saturday It Has Signed an Extension of the Scope of Services to the Production Agreement With Novavax in the Form of the Statement of Work No.
4.
The Extended Scope of Cooperation Will Include the Implementation of the Quality Test by the Company, Which is One of the Most Relevant Analyses of the Finished Product.
This Means That the Company Becomes an Entity Involved in the Processes of Releasing Products to the Market of Finished Products.
Implementation of the Feasibility Stage Will Begin Immediately and Will Be Completed As Expected by Both Parties Not Later Than by the End 2022.
The Value of the Statement of Work Depends on the Number of Analytical Tests Performed by the Company in Individual Years, With the Maximum Annual Budget Currently Agreed at the Level of $1.8 Mln.